Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 1,028 | 0 | 0 | 2,717 | 462 |
| Gross Profit | 1,028 | N/A | N/A | 2,717 | 462 |
| Operating Expenses | 54,342 | 66,099 | 63,451 | 54,316 | 17,006 |
| Operating Income | -53,314 | -66,099 | -63,451 | -51,599 | -16,544 |
| Interest Expense | 5,033 | 5,085 | 1,071 | 466 | 124 |
| Other Income | 1,763 | 3,301 | 1,248 | -982 | 0 |
| Pre-tax Income | -56,584 | -67,883 | -63,274 | -53,047 | -16,668 |
| Income Tax | N/A | N/A | 70 | 41 | 35 |
| Net Income Continuous | -56,584 | -67,883 | -63,344 | -53,088 | -16,703 |
| Minority Interests | -26,566 | -33,913 | -32,756 | -44,757 | -16,703 |
| Net Income | $-30,018 | $-33,970 | $-30,588 | $-8,331 | $N/A |
| EPS Basic Total Ops | -1.05 | -1.33 | -1.28 | -0.43 | N/A |
| EPS Basic Continuous Ops | -1.99 | -2.66 | -2.66 | -2.72 | N/A |
| EPS Diluted Total Ops | -1.05 | -1.33 | -1.28 | -0.43 | N/A |
| EPS Diluted Continuous Ops | -1.99 | -2.66 | -2.66 | -2.72 | N/A |
| EPS Diluted Before Non-Recurring Items | -1.05 | -1.33 | -1.28 | -0.43 | N/A |
| EBITDA(a) | $-53,301 | $-67,361 | $-63,677 | $-51,102 | $-15,955 |